Oppenheimer Lowers athenahealth Price Target

Oppenheimer lowered its estimates and price target for athenahealth, Inc ATHN. athenahealth is a provider of Internet-based solutions for physicians. Oppenheimer analyst Charles Rhyee said, "With recent evidence of athenaClinicals gaining traction, we cautiously increase our expectation of top-line growth for 2010. However, expected increases in sales and marketing expenses, along with revenue contributions from lower-margin products, will likely impact EPS over the near and medium term." Oppenheimer revised its CY10 EPS to $0.49 from $0.52. It revised down its CY11 EPS to $0.73 from $0.78. Oppenheimer dropped its price target for athenahealth from $28 to $22. ATHN is rated Underperform, and is currently trading at $23.03. Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free.